title: 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC).
authors: Silvia G
authors: SG
authors: Priori
authors: Carina
authors: C
authors: Blomström-Lundqvist
authors: Andrea
authors: A
authors: Mazzanti
authors: Nico
authors: N
authors: Blom
authors: Martin
authors: M
authors: Borggrefe
authors: John
authors: J
authors: Camm
authors: Perry Mark
authors: PM
authors: Elliott
authors: Donna
authors: D
authors: Fitzsimons
authors: Robert
authors: R
authors: Hatala
authors: Gerhard
authors: G
authors: Hindricks
authors: Paulus
authors: P
authors: Kirchhof
authors: Keld
authors: K
authors: Kjeldsen
authors: Karl-Heinz
authors: KH
authors: Kuck
authors: Antonio
authors: A
authors: Hernandez-Madrid
authors: Nikolaos
authors: N
authors: Nikolaou
authors: Tone M
authors: TM
authors: Norekvål
authors: Christian
authors: C
authors: Spaulding
authors: Dirk J
authors: DJ
authors: Van Veldhuisen
mesh_terms: D000208:Acute Disease; D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000235:genetics / Q000628:therapy*; D001344:Autopsy / Q000379:methods; D058406:Cardiac Resynchronization Therapy / Q000379:methods; D009202:Cardiomyopathies / Q000150:complications / Q000628:therapy; D002316:Cardiotonic Agents / Q000627:therapeutic use; D017115:Catheter Ablation / Q000379:methods; D002648:Child; D003324:Coronary Artery Disease / Q000150:complications / Q000628:therapy; D016757:Death, Sudden, Cardiac / Q000517:prevention & control*; D047548:Defibrillators; D004359:Drug Therapy, Combination; D042241:Early Diagnosis; D004638:Emergency Treatment / Q000379:methods; D005260:Female; D006330:Heart Defects, Congenital / Q000150:complications / Q000628:therapy; D016027:Heart Transplantation / Q000379:methods; D006349:Heart Valve Diseases / Q000150:complications / Q000628:therapy; D006801:Humans; D001523:Mental Disorders / Q000150:complications; D009203:Myocardial Infarction / Q000150:complications / Q000628:therapy; D009205:Myocarditis / Q000150:complications / Q000628:therapy; D009422:Nervous System Diseases / Q000150:complications / Q000628:therapy; D058687:Out-of-Hospital Cardiac Arrest / Q000628:therapy; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000628:therapy; D011322:Primary Prevention / Q000379:methods; D011788:Quality of Life; D018570:Risk Assessment; D020181:Sleep Apnea, Obstructive / Q000150:complications / Q000628:therapy; D013177:Sports / Q000502:physiology; D013318:Stroke Volume / Q000502:physiology; D013727:Terminal Care / Q000379:methods; D018487:Ventricular Dysfunction, Left / Q000150:complications / Q000628:therapy
chemical_list: D000889:Anti-Arrhythmia Agents; D002316:Cardiotonic Agents
keywords: Acute coronary syndrome; Cardiac resynchronization therapy; Cardiomyopathy; Congenital heart disease; Defibrillator; Guidelines; Heart failure; Implantable cardioverter defibrillator; Myocardial infarction; Resuscitation; Stable coronary artery disease; Sudden cardiac death; Tachycardia; Valvular heart disease; Ventricular arrhythmia